期刊
JOURNAL OF IMMUNOLOGY
卷 165, 期 8, 页码 4658-4666出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.165.8.4658
关键词
-
类别
资金
- NIMH NIH HHS [MH55795, MH50421] Funding Source: Medline
- NINDS NIH HHS [NS29719] Funding Source: Medline
ICAM-1 is a transmembrane glycoprotein of the Ig superfamily involved in cell adhesion. ICAM-1 is aberrantly expressed by astrocytes in CNS pathologies such as multiple sclerosis, experimental allergic encephalomyelitis, and Alzheimer's disease, suggesting a possible role for ICAM-1 in these disorders. ICAM-1 has been shown to he important for leukocyte diapedesis through brain microvessels and subsequent binding to astrocytes, However, other functional roles for ICAM-1 expression on astrocytes have not been well elucidated Therefore, we investigated the intracellular signals generated upon ICAM-1 engagement on astrocytes, ICAM-1 ligation by a mAb to rat ICAM-1 induced mRNA expression of proinflammatory cytokines such as IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha. Examination of cytokine protein production revealed that ICAM-1 ligation results in IL-6 secretion by astrocytes, whereas IL-1 beta and IL-1 alpha protein is expressed intracellularly in astrocytes, The involvement of mitogen-activated protein kinases (MAPKs) in ICAM-1-mediated cytokine expression in astrocytes was tested, as the MAPK extracellular signal-regulated kinase (ERK) was previously shown to be activated upon ICAM-1 engagement. Our results indicate that ERK1/ERK2, as well as p38 MAPK, are activated upon ligation of ICAM-1. Studies using pharmacological inhibitors demonstrate that both p38 MAPK and ERK1/2 are invoked in ICAM-1-induced IL-6 expression, whereas only ERK1/2 is important for IL-1 alpha and IL-1 beta expression. Our data support-the role of ICAM-1 on astrocytes as an inflammatory mediator in the CNS and also uncover a novel signal transduction pathway through p38 MAPK upon ICAM-1 ligation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据